Lenalidomide selectively inhibits in vitro growth of the malignant clone in myelodysplastic syndrome (MDS) patients with 5q deletion. - Jadersten, M; Pellagatti, A; Forsblom, A; Emanuelsson, E; Merup, M; Samuelsson, J; Wainscoat, J; Boultwood, J; Hellstorm-Lindberg, E (2005)